These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18504246)

  • 1. Erythropoietin and outcome prediction in patients with heart failure: the plot thickens..
    George J
    Eur Heart J; 2008 Jun; 29(12):1481-2. PubMed ID: 18504246
    [No Abstract]   [Full Text] [Related]  

  • 2. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
    van der Meer P; Lok DJ; Januzzi JL; de la Porte PW; Lipsic E; van Wijngaarden J; Voors AA; van Gilst WH; van Veldhuisen DJ
    Eur Heart J; 2008 Jun; 29(12):1510-5. PubMed ID: 18495690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin, haemoglobin, heart failure, and mortality.
    Diskin CJ
    Eur Heart J; 2008 Nov; 29(21):2695; author reply 2695-6. PubMed ID: 18786914
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron deficiency as a good potential prediction of chronic heart failure.
    Shi KH; Tao H; Wu JX
    Am Heart J; 2013 Oct; 166(4):e31. PubMed ID: 24093868
    [No Abstract]   [Full Text] [Related]  

  • 5. Too much, too little, or just right?: untangling endogenous erythropoietin in heart failure.
    Felker GM
    Circulation; 2010 Jan; 121(2):191-3. PubMed ID: 20048201
    [No Abstract]   [Full Text] [Related]  

  • 6. The hidden woes of anemia and sleep-disordered breathing in heart failure: killing two birds with one stone.
    Young JB
    Am Heart J; 2007 Nov; 154(5):805-7. PubMed ID: 17967582
    [No Abstract]   [Full Text] [Related]  

  • 7. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in heart failure: pathophysiologic insights and treatment options.
    Terrovitis JV; Anastasiou-Nana M; Kaldara E; Drakos SG; Nanas SN; Nanas JN
    Future Cardiol; 2009 Jan; 5(1):71-81. PubMed ID: 19371205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in the treatment of iron deficiency anemia with ferro-folgamma].
    Nikitin EN; Krasnoperova OV; Nikitin IuE
    Klin Med (Mosk); 2009; 87(3):64-7. PubMed ID: 19469261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin in patients with chronic heart failure].
    Makarova NA; Shaposhnik II; Zakharov IuM
    Klin Med (Mosk); 2009; 87(3):31-4. PubMed ID: 19469252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin and anemia: biological markers that cannot be ignored in diabetic retinopathy.
    DeNiro M; Al-Mohanna FA
    Med Hypotheses; 2012 Apr; 78(4):555-6. PubMed ID: 22336090
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.
    Adlbrecht C; Kommata S; Hülsmann M; Szekeres T; Bieglmayer C; Strunk G; Karanikas G; Berger R; Mörtl D; Kletter K; Maurer G; Lang IM; Pacher R
    Eur Heart J; 2008 Oct; 29(19):2343-50. PubMed ID: 18701467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z; Gombos T; Borgulya G; Pozsonyi Z; Prohászka Z; Jánoskuti L
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor level as surrogate peripheral blood marker of iron deficiency states.
    Koulaouzidis A; Saeed AA; Abdallah M; Said EM
    Scand J Gastroenterol; 2009; 44(1):126-7. PubMed ID: 19023699
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
    Belonje AM; Westenbrink BD; Voors AA; von Haehling S; Ponikowski P; Anker SD; van Veldhuisen DJ; Dickstein K
    Am Heart J; 2009 Jan; 157(1):91-6. PubMed ID: 19081402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.